Doximity Management
Management criteria checks 3/4
Doximity's CEO is Jeff Tangney, appointed in Apr 2010, has a tenure of 15.25 years. total yearly compensation is $17.23M, comprised of 3.5% salary and 96.5% bonuses, including company stock and options. directly owns 26.51% of the company’s shares, worth $3.06B. The average tenure of the management team and the board of directors is 4.4 years and 9.8 years respectively.
Key information
Jeff Tangney
Chief executive officer
US$17.2m
Total compensation
| CEO salary percentage | 3.48% |
| CEO tenure | 15.3yrs |
| CEO ownership | 26.5% |
| Management average tenure | 4.4yrs |
| Board average tenure | 9.8yrs |
Recent management updates
Recent updates
Getting In Cheap On Doximity, Inc. (NYSE:DOCS) Is Unlikely
Jul 08
Doximity Crushes The Rule Of 40 - Try Rule Of 58
Jul 02With EPS Growth And More, Doximity (NYSE:DOCS) Makes An Interesting Case
Jun 23At US$52.56, Is Doximity, Inc. (NYSE:DOCS) Worth Looking At Closely?
May 17Calculating The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)
May 01Shareholders Are Optimistic That Doximity (NYSE:DOCS) Will Multiply In Value
Apr 04What Doximity, Inc.'s (NYSE:DOCS) 28% Share Price Gain Is Not Telling You
Feb 23Doximity Q3 Earnings: Outpacing Even Management's Expectations
Feb 10When Should You Buy Doximity, Inc. (NYSE:DOCS)?
Jan 24Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution
Jan 13Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching
Jan 06Doximity: Strong Fundamentals And Growth Potential Makes It Attractive
Dec 06Doximity (NYSE:DOCS) Knows How To Allocate Capital
Dec 01Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%
Nov 13Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?
Nov 02Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?
Oct 15Doximity: Downgrade To Hold On Valuation Concerns
Oct 03Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors
Sep 23
Generative AI And Digital Health Innovations Fuel Robust Revenue Growth And Market Expansion
Accelerating adoption of new products and a client portal, alongside strategic positioning with top clients, suggests sustained revenue expansion.There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump
Aug 18Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns
Aug 10Doximity Faces Slower Revenue Growth As R&D Costs May Rise
Jul 23Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?
Jul 23Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)
May 17Doximity: Significant Upside Remains, But Not Until The Growth Story Returns
Apr 29Doximity: Rating Upgrade To Buy As Outlook Turns Positive
Feb 21Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan
Jan 16Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism
Nov 10CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | US$17m | US$600k | US$223m |
| Dec 31 2024 | n/a | n/a | US$201m |
| Sep 30 2024 | n/a | n/a | US$174m |
| Jun 30 2024 | n/a | n/a | US$161m |
| Mar 31 2024 | US$299k | US$295k | US$148m |
| Dec 31 2023 | n/a | n/a | US$138m |
| Sep 30 2023 | n/a | n/a | US$123m |
| Jun 30 2023 | n/a | n/a | US$119m |
| Mar 31 2023 | US$244k | US$240k | US$113m |
| Dec 31 2022 | n/a | n/a | US$119m |
| Sep 30 2022 | n/a | n/a | US$141m |
| Jun 30 2022 | n/a | n/a | US$148m |
| Mar 31 2022 | US$243k | US$240k | US$133m |
| Dec 31 2021 | n/a | n/a | US$107m |
| Sep 30 2021 | n/a | n/a | US$57m |
| Jun 30 2021 | n/a | n/a | US$30m |
| Mar 31 2021 | US$21m | US$240k | US$22m |
Compensation vs Market: Jeff's total compensation ($USD17.23M) is about average for companies of similar size in the US market ($USD13.76M).
Compensation vs Earnings: Jeff's compensation has increased by more than 20% in the past year.
CEO
Jeff Tangney (52 yo)
Mr. Jeffrey A. Tangney, also known as Jeff, Co-Founded Doximity, Inc. in 2010 and has been its Chief Executive Officer and Director since April 2010 and serves as its Chairperson. Mr. Tangney also serves a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 15.3yrs | US$17.23m | 26.51% $ 3.1b | |
| Advisor & Co-Founder | no data | US$1.52m | 0.26% $ 29.7m | |
| Chief Financial Officer | 4.4yrs | US$825.39k | 0.17% $ 19.2m | |
| General Counsel & Corporate Secretary | 4.9yrs | US$1.65m | 0.0031% $ 362.5k | |
| Co-founder and SVP People & Ops | no data | no data | no data | |
| Chief Technology Officer | no data | no data | no data | |
| Head of Investor Relations | no data | no data | no data | |
| Senior Vice President of Engineering | no data | no data | no data | |
| Senior Vice President of Product | no data | no data | no data | |
| Senior VP & GM Commercial Products | 2.2yrs | no data | no data | |
| Senior Vice President of Commercial Operations | 2.2yrs | US$5.21m | 0.011% $ 1.3m | |
| Chief Commercial Officer | no data | no data | no data |
Experienced Management: DOCS's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 15.3yrs | US$17.23m | 26.51% $ 3.1b | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 4.8yrs | US$287.10k | 0% $ 0 | |
| Independent Director | 14.3yrs | US$291.35k | 0.19% $ 22.3m | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 5.3yrs | US$282.97k | 0.0055% $ 630.4k |
Experienced Board: DOCS's board of directors are considered experienced (9.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/18 21:58 |
| End of Day Share Price | 2025/07/18 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Doximity, Inc. is covered by 24 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Nisala Weerasuriya | Berenberg |
| Allen Lutz | BofA Global Research |